Taken together, these data provide evidence that HH/GLI cooperates with JAK/STAT signaling to synergistically activate the expression of the immunosuppressive enzyme IDO1 in melanoma and non-melanoma skin cancer patients. This evidence concerns the gene IDO1 and skin cancer.